Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Deutetrabenazine Tablet

Approval Number

H20200013

CompanyTEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.

Registration Date

May 12, 2020

Drug Information

Generic Name

氘丁苯那嗪片

Trade Name

安泰坦

Dosage Form

片剂

Strength

6mg

Drug Type

化学药品

Registration Date

May 12, 2020

Expiry Date

May 11, 2025

Company Information

Applicant Company

Company NameTEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.

Company Address

145 Brandywine Parkway, West Chester, PA 19380 United States of America

Manufacturing Company

Company NameAnesta LLC

Company Address

4745 Wiley Post Way, Salt Lake City, UT 84116 United States of America

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

氘丁苯那嗪片 - NMPA 批准文号 | MedPath